Literature DB >> 19481617

Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe.

Sharika Gappoo1, Elizabeth T Montgomery, Caitlin Gerdts, Sarita Naidoo, Agnes Chidanyika, Busi Nkala, Gita Ramjee.   

Abstract

BACKGROUND: The identification of new HIV prevention methods that women can initiate themselves are urgently needed, particularly in high prevalence settings. HIV prevention trials must be designed with large sample sizes and/or substantial follow-up periods to ensure enough statistical power to measure product effectiveness. This paper describes the attendance rates of the Methods for Improving Reproductive Health in Africa (MIRA) trial, reasons for missed visits, and strategies used to retain participants; and examines demographic and behavioural predictors of retaining women.
METHODS: HIV negative, sexually active females were enrolled into the MIRA trial in Zimbabwe and South Africa. Once enrolled, women were expected to visit the clinic at 2 weeks and quarterly thereafter for 12 to 24 months. Tabulations of visit-specific retention rates are presented, along with a descriptive summary of retention strategies established prior to and in response to challenges incurred during implementation. Both univariate and multivariate logistic regression models were created in STATA to examine predictors of being retained vs. lost-to-follow-up.
RESULTS: At the three sites, the final retention rates were 94%, 93% and 89% for Zimbabwe, Durban and Johannesburg, respectively. This was achievable through intensive outreach efforts toward the latter part of the trial and a commitment from all staff. Each site implemented several retention strategies.
CONCLUSION: The high retention rates were achievable in this trial through added staff efforts and resources. Community involvement was also crucial to achieve these rates. Retention of trial participants should be considered during trial design and implemented from the onset.

Entities:  

Mesh:

Year:  2009        PMID: 19481617     DOI: 10.1016/j.cct.2009.05.002

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  14 in total

1.  Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.

Authors:  Quarraisha Abdool Karim; Ayesha B M Kharsany; Janet A Frohlich; Lise Werner; May Mashego; Mukelisiwe Mlotshwa; Bernadette T Madlala; Fanelesibonge Ntombela; Salim S Abdool Karim
Journal:  Int J Epidemiol       Date:  2010-11-03       Impact factor: 7.196

2.  Special diabetes program for Indians: retention in cardiovascular risk reduction.

Authors:  Spero M Manson; Luohua Jiang; Lijing Zhang; Janette Beals; Kelly J Acton; Yvette Roubideaux
Journal:  Gerontologist       Date:  2011-06

Review 3.  Traditional, complementary, and alternative medical cures for HIV: rationale and implications for HIV cure research.

Authors:  Xin Pan; Alice Zhang; Gail E Henderson; Stuart Rennie; Chuncheng Liu; Weiping Cai; Feng Wu; Joseph D Tucker
Journal:  Glob Public Health       Date:  2017-12-13

4.  Participant and site characteristics related to participant retention in a diabetes prevention translational project.

Authors:  Luohua Jiang; Spero M Manson; Edward J Dill; Janette Beals; Ann Johnson; Haixiao Huang; Kelly J Acton; Yvette Roubideaux
Journal:  Prev Sci       Date:  2015-01

5.  Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: the Breastfeeding, Antiretrovirals and Nutrition study experience.

Authors:  Christopher J Sellers; Hana Lee; Charles Chasela; Dumbani Kayira; Alice Soko; Innocent Mofolo; Sascha Ellington; Michael G Hudgens; Athena P Kourtis; Caroline C King; Denise J Jamieson; Charles van der Horst
Journal:  Clin Trials       Date:  2014-12-17       Impact factor: 2.486

6.  Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa.

Authors:  Gita Ramjee; Nicola Coumi; Nozizwe Dladla-Qwabe; Shay Ganesh; Sharika Gappoo; Roshini Govinden; Vijayanand Guddera; Rashika Maharaj; Jothi Moodley; Neetha Morar; Sarita Naidoo; Thesla Palanee
Journal:  AIDS Res Ther       Date:  2010-04-23       Impact factor: 2.250

7.  How ethical is your clinical trial?

Authors:  L Miller; M Folayan; D Allman; B Nkala; L M Kasirye; L R Mingote; G Calazans; R Mburu; F Ntombela; M Ditmore
Journal:  Int J Clin Pract       Date:  2010-06-16       Impact factor: 2.503

8.  The role of session zero in successful completion of chronic disease self-management program workshops.

Authors:  Luohua Jiang; Matthew Lee Smith; Shuai Chen; SangNam Ahn; Kristie P Kulinski; Kate Lorig; Marcia G Ory
Journal:  Front Public Health       Date:  2015-04-27

9.  Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa.

Authors:  Busisiwe Magazi; Jonathan Stadler; Sinead Delany-Moretlwe; Elizabeth Montgomery; Florence Mathebula; Miriam Hartmann; Ariane van der Straten
Journal:  BMC Womens Health       Date:  2014-07-28       Impact factor: 2.809

10.  Cognitive mapping: using local knowledge for planning health research.

Authors:  Jonathan Stadler; Charles Dugmore; Emilie Venables; Catherine MacPhail; Sinead Delany-Moretlwe
Journal:  BMC Med Res Methodol       Date:  2013-07-26       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.